Influence of mast cells on outcome after heterotopic cardiac transplantation in rats

Transplant International

Volumn 20, Issue 3, 2007, Pages 256-265

  Boerma, Marjan ^a,b   Fiser, William P ^b   Hoyt, Grant ^c   Berry, Gerald J ^d   Joseph, Lija ^e   Joseph, Jacob ^e   Wang, Junru ^a   Crew, Mark D ^a   Robbins, Robert C ^c   Hauer Jensen, Martin ^a  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal models; Cardiac transplantation; Graft survival; Mast cells

Indexed keywords

CYCLOSPORIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; FIBRIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELL PROTECTION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBRIN DEPOSITION; FIBROSIS; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HETEROTOPIC TRANSPLANTATION; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIA; MALE; MAST CELL; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CYTOKINES; GRAFT SURVIVAL; HEART TRANSPLANTATION; MALE; MAST CELLS; MODELS, ANIMAL; RATS; TRANSPLANTATION, HETEROTOPIC;

EID: 33846942263     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00420.x     Document Type: Article

References (49)

1. Koskinen PK, Kovanen PT, Lindstedt KA, Lemstrom KB. Mast cells in acute and chronic rejection of rat cardiac allografts - a major source of basic fibroblast growth factor. Transplantation 2001; 71: 1741.
2. Li QY, Raza-Ahmad A, MacAulay MA, et al. The relationship of mast cells and their secreted products to the volume of fibrosis in posttransplant hearts. Transplantation 1992; 53: 1047.
3. Zweifel M, Hirsiger H, Matozan K, Welle M, Schaffner T, Mohacsi P. Mast cells in ongoing acute rejection: increase in number and expression of a different phenotype in rat heart transplants. Transplantation 2002; 73: 1707.
4. Boyce JA. Mast cells: beyond IgE. J Allergy Clin Immunol 2003; 111: 24.
5. Sillaber C, Baghestanian M, Bevec D, et al. The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis. J Immunol 1999; 162: 1032.
6. Valent P, Baghestanian M, Bankl HC, et al. New aspects in thrombosis research: possible role of mast cells as profibrinolytic and antithrombotic cells. Thromb Haemost 2002; 87: 786.
7. Wojta J, Kaun C, Zorn G, et al. C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils. Blood 2002; 100: 517.
8. Crivellato E, Beltrami CA, Mallardi F, Ribatti D. The mast cell: an active participant or an innocent bystander? Histol Histopathol 2004; 19: 259.
9. Hara M, Ono K, Hwang MW, et al. Evidence for a role of mast cells in the evolution to congestive heart failure. J Exp Med 2002; 195: 375.
10. Shiota N, Rysa J, Kovanen PT, Ruskoaho H, Kokkonen JO, Lindstedt KA. A role for cardiac mast cells in the pathogenesis of hypertensive heart disease. J Hypertens 2003; 21: 1935.
11. Boerma M, Wang J, Wondergem J, et al. Influence of mast cells on structural and functional manifestations of radiation-induced heart disease. Cancer Res 2005; 65: 3100.
12. Joseph J, Kennedy RH, Devi S, Wang J, Joseph L, Hauer-Jensen M. Protective role of mast cells in homocysteine-induced cardiac remodeling. Am J Physiol Heart Circ Physiol 2005; 288: H2541.
13. Maurer M, Wedemeyer J, Metz M, et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 2004; 432: 512.
14. Zheng H, Wang J, Hauer-Jensen M. Role of mast cells in early and delayed radiation injury in rat intestine. Radiat Res 2000; 153: 533.
15. Wang Y, Shiota N, Leskinen MJ, Lindstedt KA, Kovanen PT. Mast cell chymase inhibits smooth muscle cell growth and collagen expression in vitro: transforming growth factor-beta1-dependent and -independent effects. Arterioscler Thromb Vasc Biol 2001; 21: 1928.
16. Lu LF, Lind EF, Gondek DC, et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006; 442: 997.
17. Ehrenreich H, Burd PR, Rottem M, et al. Endothelins belong to the assortment of mast cell-derived and mast cell-bound cytokines. New Biol 1992; 4: 147.
18. Hultner L, Ehrenreich H. Mast cells and endothelin-1: a life-saving biological liaison? Trends Immunol 2005; 26: 235.
19. Metsarinne KP, Vehmaan-Kreula P, Kovanen PT, et al. Activated mast cells increase the level of endothelin-1 mRNA in cocultured endothelial cells and degrade the secreted Peptide. Arterioscler Thromb Vasc Biol 2002; 22: 268.
20. Wypij DM, Nichols JS, Novak PJ, Stacy DL, Berman J, Wiseman JS. Role of mast cell chymase in the extracellular processing of big-endothelin-1 to endothelin-1 in the perfused rat lung. Biochem Pharmacol 1992; 43: 845.
21. Aharinejad S, Krenn K, Paulus P, et al. Differential role of TGF-beta1/bFGF and ET-1 in graft fibrosis in heart failure patients. Am J Transplant 2005; 5: 2185.
22. Ferri C, Properzi G, Tomassoni G, et al. Patterns of myocardial endothelin-1 expression and outcome after cardiac transplantation. Circulation 2002; 105: 1768.
23. Sihvola RK, Pulkkinen VP, Koskinen PK, Lemstrom KB. Crosstalk of endothelin-1 and platelet-derived growth factor in cardiac allograft arteriosclerosis. J Am Coll Cardiol 2002; 39: 710.
24. Niwa Y, Kasugai T, Ohno K, et al. Anemia and mast cell depletion in mutant rats that are homozygous at "white spotting (Ws)" locus. Blood 1991; 78: 1936.
25. Vriens PW, Blankenberg FG, Stoot JH, et al. The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. J Thorac Cardiovasc Surg 1998; 116: 844.
26. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 1710.
27. James JD, Hauer-Jensen M. Effects of fixative and fixation time for quantitative computerized image analysis of immunohistochemical staining. J Histotechnol 2001: 22: 109.
28. Wang J, Zheng H, Hollenberg MD, Wijesuriya SJ, Ou X, Hauer-Jensen M. Up-regulation and activation of proteinase-activated receptor 2 in early and delayed radiation injury in the rat intestine: influence of biological activators of proteinase-activated receptor 2. Radiat Res 2003; 160: 524.
29. Labarrere CA, Nelson DR, Park JW. Pathologic markers of allograft arteriopathy: insight into the pathophysiology of cardiac allograft chronic rejection. Curr Opin Cardiol 2001; 16: 110.
30. Torry RJ, Bai L, Miller SJ, Labarrere CA, Nelson D, Torry DS. Increased vascular endothelial growth factor expression in human hearts with microvascular fibrin. J Mol Cell Cardiol 2001; 33: 175.
31. Kehrl JH, Wakefield LM, Roberts AB, et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986; 163: 1037.
32. Chan SY, Goodman RE, Szmuszkovicz JR, Roessler B, Eichwald EJ, Bishop DK. DNA-liposome versus adenoviral mediated gene transfer of transforming growth factor beta1 in vascularized cardiac allografts: differential sensitivity of CD4+ and CD8+ T cells to transforming growth factor beta1. Transplantation 2000; 70: 1292.
33. Qin L, Chavin KD, Ding Y, et al. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Immunosuppression with TGF-beta 1 or vIL-10. Transplantation 1995; 59: 809.
34. Honjo K, Xu X, Bucy RP. CD4+ T-cell receptor transgenic T cells alone can reject vascularized heart transplants through the indirect pathway of alloantigen recognition. Transplantation 2004; 77: 452.
35. Exner BG, Que X, Mueller YM, Domenick MA, Neipp M, Ildstad ST. Alpha beta TCR+ T cells play a nonredundant role in the rejection of heart allografts in mice. Surgery 1999; 126: 121.
36. Heidecke CD, Hancock WW, Jakobs F, et al. Alpha/beta-T cell receptor-directed therapy in rat cardiac allograft recipients. Treatment prior to alloantigen exposure prevents sensitization and abrogates accelerated rejection. Transplantation 1995; 59: 78.
37. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005; 23: 749.
38. Miyazawa S, Hotta O, Doi N, Natori Y, Nishikawa K, Natori Y. Role of mast cells in the development of renal fibrosis: use of mast cell-deficient rats. Kidney Int 2004; 65: 2228.
39. Rivera A, Rotter MA, Brugnara C. Endothelins activate Ca(2+)-gated K(+) channels via endothelin B receptors in CD-1 mouse erythrocytes. Am J Physiol 1999; 277: C746.
40. Sakashita K, Oonishi T, Ishioka N, Uyesaka N. Endothelin-1 improves the impaired filterability of red blood cells through the activation of protein kinase C. Jpn J Physiol 1999; 49: 113.
41. Simonson MS, Robinson AV, Schulak JA, Hricik DE. Inhibition of endothelin-1 improves survival and vasculopathy in rat cardiac transplants treated with cyclosporine. Transplantation 2002; 73: 1054.
42. Yamaguchi A, Miniati DN, Hirata K, Hoyt EG, Robbins RC. Ex vivo blockade of endothelin-1 inhibits graft coronary artery disease in a rodent cardiac allograft model. J Heart Lung Transplant 2002; 21: 417.
43. Akgul A, Skrabal CA, Thompson LO, et al. Role of mast cells and their mediators in failing myocardium under mechanical ventricular support. J Heart Lung Transplant 2004; 23: 709.
44. Cynshi O, Satoh K, Higuchi M, Imai N, Kawaguchi T, Hirashima K. Effects of recombinant human erythropoietin on anaemic W/Wv and Sl/Sld mice. Br J Haematol 1990; 75: 319.
45. Ashman LK. The biology of stem cell factor and its receptor C-kit. Int J Biochem Cell Biol 1999; 31: 1037.
46. Matos ME, Schnier GS, Beecher MS, Ashman LK, William DE, Caligiuri MA. Expression of a functional c-kit receptor on a subset of natural killer cells. J Exp Med 1993; 178: 1079.
47. Perdue MH, Masson S, Wershil BK, Galli SJ. Role of mast cells in ion transport abnormalities associated with intestinal anaphylaxis. Correction of the diminished secretory response in genetically mast cell-deficient W/Wv mice by bone marrow transplantation. J Clin Invest 1991; 87: 687.
48. Santos J, Yang PC, Soderholm JD, Benjamin M, Perdue MH. Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat. Gut 2001; 48: 630.
49. Yang PC, Berin MC, Yu L, Perdue MH. Mucosal pathophysiology and inflammatory changes in the late phase of the intestinal allergic reaction in the rat. Am J Pathol 2001; 158: 681.